This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. (CRL) advanced 1.25% to $222.35 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&amp;P 500 Index  rising 0.50% to 6,950.23 and the Dow Jones Industrial Average  rising 0.64% to 49,412.40.
The stock's rise snapped a two-day losing streak.
Charles River Laboratories International Inc. closed 2.85% below its 52-week high of $228.88, which the company reached on January 13th.
The stock outperformed some of its competitors Monday, as Labcorp Holdings Inc. (LH) rose 0.27% to $267.38, Alnylam Pharmaceuticals Inc. (ALNY) rose 0.94% to $361.35, and Bio-Techne Corp. (TECH) fell 0.78% to $67.63.
Trading volume (440,973) remained 342,833 below its 50-day average volume of 783,806.
Data source: Dow Jones Market Data, FactSet. Data compiled January 26, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-26-26 1717ET

UDOW

<p>Charles River Laboratories International Inc. (CRL) shares rose 1.25% to $222.35 on a strong trading day, outperforming competitors like Labcorp Holdings Inc. and Alnylam Pharmaceuticals Inc. The S&P 500 Index increased by 0.50%, while the Dow Jones Industrial Average rose by 0.64%. CRL's stock is currently 2.85% below its 52-week high of $228.88. Trading volume was below the 50-day average, with 440,973 shares traded.</p>

- Shares of Charles River Laboratories International Inc. (CRL) increased by 1.25% to $222.35 amidst a positive trading session for the stock market.  
- The stock ended 2.85% below its 52-week high of $228.88, which was reached on January 13th, and trading volume was 440,973, below the 50-day average.  
- Comparatively, competitors had mixed performances, with Labcorp Holdings Inc. rising 0.27% and Bio-Techne Corp. declining 0.78%.

Dow Jones

ProShares Ultra Dow30 ETF

First Trust NYSE Arca Biotech Index Fd

Pro UltrPro Dow30

Invesco Nasdaq Biotechnology ETF

Direxion Daily Biotech Top 5 Bull 2X ETF

Ark Genomic Revolution ETF

Guggenheim DJIA Ave Div

iShares Genomics Immunology and Healthcare ETF

Ps S&P Low Vol

Charles River Laboratorie

Dow Jones Industrial Average

iShares Core S&P 500

Proshares Ultra Nasdaq Biotech

Invesco S&P 500 Eq Wgt ETF

SPDR S&P 500

iShares US Pharma

VG S&P 500

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

iShares Biotechnology ETF

ALPS Medical Breakthrough

iShares Dow Jones US

S&P 500

SPDR Djia

Alnylam Pharma

Labcorp

SPDR S&P Biotech

Dow Jones U.S. Index

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day